Clinical Trials Browser

Phase 1 × Withdrawn × lifileucel × Clear all

NCT06190249 2025-06-05

Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Phase 1 Withdrawn

Melanoma